Staff Reports
The Trump administration has finalized a major update to the Transparency in Coverage rule that could finally make health care prices understandable and usable for everyday Americans. The rule adds a required executive attestation, forces machine‑readable files into a single open standard, and makes plans give cost estimates by phone as well as online. Patient advocates and conservative policy groups are cheering, and hospitals and insurers are quietly watching to see if the rule actually gets enforced.
What the new Transparency in Coverage rule requires
The Departments of Health and Human Services, Labor, and Treasury tightened the rules for how insurers and group health plans publish negotiated prices. Each machine‑readable file must now include an attestation that the data is “true, accurate, and complete,” and it must encode the name of a senior official — think CEO or president — who signs off on it. The rule also standardizes file formats so third‑party tools can actually use the data, expands out‑of‑network price info, updates drug pricing files, and requires plans to give personalized cost‑sharing estimates by phone as well as online.
Why patient advocates and conservatives applaud the move
This is the kind of common‑sense reform voters like. Patient advocates called the executive attestation a “breakthrough for compliance,” saying it will stop overcharges and hold insurers and hospitals accountable. HHS leaders framed the change as delivering on a promise that Americans should know what care will cost before they get it. For conservatives, the win is simple: give patients and employers real prices, and market pressure will drive down the most egregious costs.
Don’t get comfortable — enforcement and usability still matter
All the press releases in the world won’t help if the data is a mess or nobody enforces the rules. Past transparency efforts produced giant, unusable files and spotty compliance by hospitals and insurers. The new attestation raises the stakes, but it only has teeth if CMS and the other agencies audit, penalize bad actors, and publish clear technical specs. Third‑party developers must build useful front ends so consumers can shop. Expect litigation from parties who prefer opaque pricing, and expect the battle to move to courtrooms and regulator checklists.
This rule is a real chance to shift power from insiders to patients and employers — but it will take Republican pressure and steady oversight to make it work. President Trump deserves credit for pushing transparency, but now Congress and regulators must follow through. If they do, Americans could finally start seeing prices they can trust and use. If they don’t, hospitals and insurers will go right back to hiding behind complicated files and friendly charts. The choice will be clear: real accountability or more excuses.
